TITLE

The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model

AUTHOR(S)
Hourioux, C.; Patient, R.; Morin, A.; Blanchard, E.; Moreau, A.; Trassard, S.; Giraudeau, B.; Roingeard, P.
PUB. DATE
September 2007
SOURCE
Gut;Sep2007, Vol. 56 Issue 9, p1302
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background and aims: The prevalence and severity of liver steatosis are higher in patients infected with genotype 3 hepatitis C virus (HCV) than in patients infected with other genotypes. HCV core protein is known to affect lipid metabolism, inducing lipid droplet accumulation both in vitro and in vivo. An in vitro cellular model was used to investigate whether an HCV core protein with residues specific to genotype 3 increased this phenomenon. Methods: Sequence comparisons for HCV core protein domain II, which is known to interact with lipid droplets, identified the phenylalanine (F) residue at position 164 as the only residue specific to genotype 3. The area covered by lipid droplets in sections of cells producing a wild-type genotype la HCV core protein was compared with that in cells producing a Y164F mutant protein. Results: Cumulative lipid droplet area was significantly greater in sections of cells producing the Y164F mutant HCV core protein than in cells producing the wild-type protein (p<0.001). The frequency of cell sections containing more than 3 μm² of lipid droplets, in particular, was higher for the mutant than for the wild-type protein. Conclusion: The data provide a molecular explanation for HCV genotype 3-specific lipid accumulation. This difference between genotypes may be due to phenylalanine having a higher affinity for lipids than tyrosine (Y). These observations provide useful information for further studies of the mechanisms involved in HCV-induced steatosis.
ACCESSION #
26437244

 

Related Articles

  • Does PPARγ2 Gene Pro12Ala Polymorphism Affect Nonalcoholic Fatty Liver Disease Risk? Evidence from a Meta-Analysis. Sahebkar, Amirhossein // DNA & Cell Biology;Apr2013, Vol. 32 Issue 4, p188 

    Genetic factors can substantially contribute to the pathogenesis of nonalcoholic fatty liver disease (NAFLD). A missense Pro12Ala substitution in the PPARγ2 gene ( rs1801282) has been studied in relation with NAFLD risk in different ethnic groups, but findings have been inconclusive. The aim...

  • Is rs8099917 Polymorphism of IL-28B Gene a Good Predictor of Response to Therapy of HCV than rs12979860? An Egyptian Study. Shaker, Olfat; Rashad, Amal; Aziz, Ghada; Raziky, Maissa // Cell Biochemistry & Biophysics;Jan2015, Vol. 71 Issue 1, p307 

    Hepatitis C virus (HCV) infection is the major etiology of chronic liver disease. Polymorphisms in the IL-28B gene region are important in predicting outcome following therapy for chronic hepatitis C virus infection. The aim of this study was to detect the relationship between IL-28B...

  • GENETIC POLYMORPHYSMS IN HEPATITIS C TREATMENT. Roşu, Alexandra Floriana; Gheonea, Ioana Andreea; Zlatian, Ovidiu; Şerban Sosoi, Simona Veronica; Ciurea, Tudorel // Internal Medicine / Medicina Interna;2015, Vol. 12 Issue 5, p47 

    Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease worldwide, causing hepatic alterations, from minimal to extensive fibrosis and cirrhosis, with or without hepatocellular carcinoma (HCC). Genetic factors controlling the host immune response play a pivotal role...

  • PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver Disease. Salameh, Habeeb; Raff, Evan; Erwin, Angelika; Seth, Devanshi; Nischalke, Hans Dieter; Falleti, Edmondo; Burza, Maria Antonella; Leathert, Julian; Romeo, Stefano; Molinaro, Antonio; Corradini, Stefano Ginanni; Toniutto, Pierluigi; Ulrich, Spengler; Daly, Ann; Day, Christopher P; Kuo, Yong-Fang; Singal, Ashwani K // American Journal of Gastroenterology;Jun2015, Vol. 110 Issue 6, p846 

    OBJECTIVES:The genetic polymorphism with an isoleucine-to-methionine substitution at position 148 (rs738409 C>G) in the patatin-like phospholipase domain protein 3 (PNPLA3) gene confers risk of steatosis. PNPLA3 polymorphism is shown to be associated with alcoholic liver disease (ALD). We...

  • Liver Fibrosis, Host Genetic and Hepatitis C Virus Related Parameters as Predictive Factors of Response to Therapy against Hepatitis C Virus in HIV/HCV Coinfected Patients. Corchado, Sara; López-Cortés, Luis F.; Rivero-Juárez, Antonio; Torres-Cornejo, Almudena; Rivero, Antonio; Márquez-Coello, Mercedes; Girón-González, José-Antonio // PLoS ONE;Jul2014, Vol. 9 Issue 7, p1 

    Objective: To establish the role of liver fibrosis as a predictive tool of response to pegylated interferon alpha (Peg-IFN) and ribavirin (RBV) treatment in human immunodeficiency (HIV)/hepatitis C virus (HCV) coinfected patients, in addition to recognized predictive factors (HCV load, HCV...

  • Calendar of Courses, Symposiums and Conferences.  // American Journal of Gastroenterology;Dec2013, Vol. 108 Issue 12, p1940 

    A calendar of courses offered by the journal for the U.S. from December 2013 till May 2014 is presented which include the ACG Southern Regional Course, the 29th Annual New Treatments in Chronic Liver Disease, and the Hepatitis C Management State of The Art.

  • Hepatitis C Virus-Induced Hepatocellular Steatosis. Castera, Laurent; Chouteau, Philippe; Hezode, Christophe; Zafrani, Elie-Serge; Dhumeaux, Daniel; Pawlotsky, Jean-Michel // American Journal of Gastroenterology;Mar2005, Vol. 100 Issue 3, p711 

    Two distinct forms of hepatocellular steatosis can be seen in patients with chronic hepatitis C virus (HCV) infection. Classical metabolic risk factors for hepatocellular steatosis account for the vast majority of cases of steatosis in patients infected by non-genotype 3 HCV strains. In...

  • Role of -55CT polymorphism of UCP3 gene on non alcoholic fatty liver disease and insulin resistance in patients with obesity. Aller, R.; De Luis, D. A.; Izaola, O.; Sagrado, M. González; Conde, R.; Alvarez, T.; Pacheco, D.; Velasco, M. C. // Nutricion Hospitalaria;jul-ago2010, Vol. 25 Issue 4, p572 

    Background and aims: Some studies have pointed to a role of UCP3 in the regulation of biochemical and fat parameters in overweight patients. The aim of our study was to investigate the influence of -55CT polymorphism of UCP3 gene (rs1800849) on histological changes and insulin resistance in...

  • Influence of G1359A polimorphysm of the cannabinoid receptor gene (CNR1) on insulin resistance and adipokines in patients with non alcoholic fatty liver disease. Aller, R.; de Luis, D. A.; Pacheco, D.; Velasco, M. C.; Conde, R.; Izaola, O.; González Sagrado, M. // Nutricion Hospitalaria;sep/oct2012, Vol. 27 Issue 5, p1637 

    Background: Considering the evidence that endogenous cannabinoid system plays a role in metabolic aspects of body weight and metabolic syndrome components such as non alcoholic fatty liver disease (NAFLD). The aim of our study was to investigate the influence of this polymorphism on insulin...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics